Table 3 Changes in FPG, FI, 2 h-OGTT, HbA1c, and HOMA-IR after intervention (at Day 84) in the treatment and control groups, mean ± SD (Significance level ANOVA p value < 10− 5)
Parameters | Treatment Group (n = 17) | Treatment Group (n = 17) | Control Group (n = 17) | Control Group (n = 17) | p value Treatment vs. Control |
|---|---|---|---|---|---|
Day 0 | Day 84 | Day 0 | Day 84 | Day 84 | |
FPG (mmol/L) | 6.75 ± 0.23 | 5.33 ± 0.28*¥ | 6.31 ± 0.44 | 6.16 ± 0.44 | p<10− 5 |
FI (µIU/mL) | 9.81 ± 0.36 | 7.88 ± 0.52* | 9.85 ± 0.35 | 9.76 ± 0.37 | p < 10− 5 |
2 h-OGTT (mmol/L) | 10.44 ± 0.52 | 8.12 ± 0.40* | 9.71 ± 0.63 | 9.68 ± 0.51 | p < 10− 5 |
HbA1c (%) | 6.40 ± 0.20 | 5.43 ± 0.21*¥ | 6.15 ± 0.26 | 6.10 ± 0.24 | p < 10− 5 |
HOMA-IR (units) | 3.61 ± 0.31 | 2.41 ± 0.14* | 3.45 ± 0.26 | 3.40 ± 0.28 | p < 10− 5 |